WO1998056940A1 - Hair growth activating composition - Google Patents

Hair growth activating composition Download PDF

Info

Publication number
WO1998056940A1
WO1998056940A1 PCT/JP1998/002525 JP9802525W WO9856940A1 WO 1998056940 A1 WO1998056940 A1 WO 1998056940A1 JP 9802525 W JP9802525 W JP 9802525W WO 9856940 A1 WO9856940 A1 WO 9856940A1
Authority
WO
WIPO (PCT)
Prior art keywords
general formula
hair
compound
growth
triprenylphenol
Prior art date
Application number
PCT/JP1998/002525
Other languages
French (fr)
Japanese (ja)
Inventor
Seigo Hanada
Mina Kanda
Megumi Furui
Masato Sugiyama
Original Assignee
Mitsubishi Chemical Corporation
Sansho Seiyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corporation, Sansho Seiyaku Co., Ltd. filed Critical Mitsubishi Chemical Corporation
Publication of WO1998056940A1 publication Critical patent/WO1998056940A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • the present invention relates to a hair-growth active composition, and more particularly to a hair-growth active composition containing a triprenylphenylninol derivative as an active ingredient.
  • hair growth and hair restoration agents containing various chemicals have been used.
  • Representative active ingredients include vitamin E, which has a blood circulation improvement effect, and sempri extract, and female hormones such as cystine and methionine as amino acids that are nutritional supplements.
  • estradiol, ethinyl estradiol and the like are known, and a plurality of pharmacologically active ingredients corresponding to various causes of hair loss are used in combination for the prevention and treatment of alopecia.
  • the present inventors have focused on the fact that microorganisms produce a variety of physiologically active substances, and as a result of searching for substances having hair-growth activity in microbial metabolites, have found that an excellent hair-growth effect can be obtained in a culture solution of Stachybotrys.
  • the present inventors have found a group of compounds having the compound, and have completed the present invention. That is, the gist of the present invention is represented by the following general formula (I)
  • R 4 represents —H or —OH.
  • a salt or a hydrate or solvate thereof as an active ingredient in a hair-growth active composition comprising as an active ingredient a triprenylphenol derivative represented by the formula:
  • a triprenyl phenol derivative is used.
  • triprenylphenol derivatives are examples of triprenylphenol derivatives.
  • R 1 is —H
  • R 2 is —H
  • R 3 is —CH 2 —COH (CH 3 ) 2
  • R 4 is —H
  • R 1 is —H
  • R 2 is —0 H
  • R 4 is —H Hair restoration active compositions are preferred.
  • the hair-growth active composition is also preferable in the present invention.
  • a microorganism belonging to the genus Stachybotrys and capable of producing the triprenyl phenol derivative represented by the above general formula (I) is cultured in a medium, and the compound is produced and accumulated in the culture.
  • a method for producing a tribrenylphenol derivative represented by the general formula (I), wherein the compound is collected from the culture is cultured in a medium, a compound is produced and accumulated in the culture, the compound is collected from the culture, and subjected to structural analysis based on its physical properties. The structure of ⁇ 5 was determined.
  • the triprenyl phenol derivative represented by the above general formula (I) can be used as an active ingredient of a hair restorer, a hair restorer or an agent for preventing or treating hair loss.
  • Examples of the salt that can be formed by the triprenylphenol derivative represented by the general formula (I) include alkali metal salts such as sodium salts and potassium salts, magnesium salts, magnesium salts, and the like. Examples include alkaline earth metal salts such as calcium salts, organic base salts such as tetramethylammonium salt, and ammonium salts. Further, the triprenyl phenylol derivative represented by the above general formula (I) and a salt thereof can also form a hydrate or a solvate.
  • the triprenylphenol derivative represented by the above general formula (I) can be produced by a microorganism belonging to Stachybotrys.
  • microorganisms include microorganisms belonging to Stachybotrys ′ elegance, such as Stachybotrys elegans D1087.
  • Stakibotris' Elegance D 1 087 is a microorganism isolated from the natural soil by the present inventors and deposited with the Institute of Biotechnology, National Institute of Advanced Industrial Science and Technology as FE RM BP-637 Have been.
  • Stachybotrys elegance D1087 (Stachybotrys elegans D1087) are as follows.
  • the mycological properties of Sugi Kibotris' Elegance D 1 087 are as follows.
  • Miura medium LCA
  • Conidiophores are finite, well-differentiated, solitary or rarely branched, erect, often slightly bent, number of partitions: 2-4, colorless, surface smooth, length 74-117 (average 99) m, width 3.8-4.7 m (average 3.9 m) at base, tapered 2.8-3.4 m (average 3.1) m at top. Three to seven phyllids are formed in a ring form from the top of the conidiophores, sub-club-shaped, the surface is smooth, 10.6-16.6 (average 13.7) m in length, 3.4-5.9 (average 4.3) in width ⁇ m.
  • Conidia show apical and filo-type conidium formation, congregate at the apical end of the fiber to produce a viscous conidium mass, unicellular, lemon-shaped or spindle-shaped, colorless and transparent, and the surface is smooth and long. 9.4 ⁇ 12.5 (average 11.0) / m, width 3.8 ⁇ 5.6 (average 4.7) m.
  • This strain (D1087) has 1) formation of a filamentous conidium, 2) distinct differentiation, solitary or irregular branching, and 3) rotation of a filament at the upper end of the conidiophore. 4) Conidia are formed basophilically and have the characteristic that they aggregate at the ends of the phiride to form a viscous mass. Based on the above properties, this strain belongs to the Stachybotrys genus of the Deutero mycotina-Hyphomycetes class.
  • the above bacteria are cultured in a medium containing nutrients that can be used by ordinary microorganisms.
  • nutrients glucose, syrup, dextrin, sucrose, starch, molasses, animal and vegetable oils and the like can be used.
  • the nitrogen source soybean flour, wheat germ, corn steep liquor, cottonseed birch, meat extract, peptone, yeast extract, ammonium sulfate, sodium nitrate, urea and the like can be used.
  • Other if necessary, It is beneficial to add sodium, calcium, calcium, magnesium, cobalt, chlorine, phosphoric acid, sulfuric acid and other inorganic salts capable of forming ions.
  • organic and inorganic salts that assist the growth of the fungus and promote the production of the triprenylphenol derivative can be appropriately added.
  • a culturing method under aerobic conditions particularly a liquid shin culture
  • the temperature suitable for culturing is 20 ° C to 30 ° C, but in most cases, culturing is performed at around 26 ° C to 29 ° C.
  • the production of the triprenylphenol derivative varies depending on the culture medium and culture conditions, but usually the accumulation is maximum between 4 and 10 days. Stop the culture when the amount of accumulated triprenyl phenol derivative in the culture reaches the maximum, and purify the target substance from the culture solution.
  • the triprenyl phenol derivatives are fat-soluble, they can be purified from cultures by utilizing their properties. That is, a solvent extraction method using ethyl acetate, black form, etc., a synthetic adsorbent such as silica gel, alumina, octadecyl silica gel, Diaion HP-20 (manufactured by Mitsubishi Chemical Corporation), or Sephadex LH-2 0 Column chromatography using a gel filtration agent such as [Pharmacia] etc., and preparative chromatography using a silica gel as a carrier, and in some cases, recrystallization with various organic solvents or water are effective. It is.
  • a solvent extraction method using ethyl acetate, black form, etc. a synthetic adsorbent such as silica gel, alumina, octadecyl silica gel, Diaion HP-20 (manufactured by Mitsubishi Chemical Corporation), or Sephadex LH-2 0
  • the hair-growth active composition of the present invention needs to contain at least one compound selected from the compounds represented by the above general formula (I), but does not adversely affect the purpose of use. As far as possible, other active compounds and additives can be included.
  • the content of these compounds in the composition is not limited as it can vary according to the combination with other active compounds and additives and the dosage form. However, it is generally from 0.0001 to 20% by weight, preferably from 0.01 to 5% by weight, based on the total composition weight.
  • Oils such as ethylene (8 mol) oleyl alcohol ether, glyceryl monooleate, etc., blood flow enhancers such as nicotinic acid amide, benzyl nicotinate, vitamin E-acetate, sempli extract, glycyrrhizic acid, Inflammatory agents such as Nokitiol, hormones such as ethinyl estradiol, i: "Hair root activator such as Yumin H, pantothenyl ethyl ether, sorbitan monolaurate, monono, sorbitan luminitate.
  • Sorbitan sesquioleate polyoxyethylene sorbitan monolaurate, polyethylene glycol monooleate, polyoxyethylene alkyl ether, polyglycol gester, lauryljetanolamide, fatty acid isopropanolamide, etc.
  • Nonionic surfactants sodium palmitate, sodium laurate, sodium lauryl sulfate, potassium lauryl sulfate, triethanolamine alkyl sulfate, Oil, Ronia dodecylbenzene sulfate, polyoxyethylene cured Anionic surfactants such as macar oil maleic acid, semi-polar surfactants such as lauryl dimethyl amine oxide and olein dimethyl amine oxide, surfactants, moisturizers, thickeners, preservatives, antioxidants, fragrances And coloring agents.
  • the hair-growth active composition of the present invention in combination with such other active compounds and additives is not limited in its dosage form and is optional.
  • hair growth promotion and It can be used as a therapeutic or preventive agent for hair loss or as a cosmetic preparation, as a hair tonic, hair cream, shampoo, rinse, etc. having a hair growth promoting and hair loss preventing effect.
  • Seed culture syrup 2.0%, soybean meal 1.0%, soybean oil 0.15%, Sangurei down 0.25%, FeS0 4 - 7H 2 0 0.0005%, NiCl 2 ⁇ 6H 2 0 0.00005 CaC0 3 culture locations containing 0.1% (P H6 .0) was dispensed into two 200 ml Erlenmeyer flasks in 40 ml aliquots and autoclaved at 121 ° C. for 20 minutes.
  • One platinum loop of Stachybotrys elegance D 1 087 (FE RM BP- 6 3 7 3) was inoculated on this, and the cells were cultured at 27 ° C for 3 days at 210 rpm. .
  • Main culture syrup 2.0%, soybean meal 1.0%, soybean oil 0.15%, Sangurei emissions 0: 25%, FeS0 4 - 7H 2 0 0.0005%, NiCl 2 ⁇ 6H 2 0 0.00005 CaC0 3 culture locations containing 0.1% ( pH 6.0) was dispensed into 100 ml 500 ml Erlenmeyer flasks in 80 ml aliquots and autoclaved at 121 ° C for 20 minutes. This was inoculated with 0.4 ml of a seed culture solution and cultured at 27 ° C. for 8 days at 210 rpm for 8 days.
  • the obtained acetate extract was concentrated to 4 liters under reduced pressure. This was extracted with 4 liters of ethyl acetate, and ethyl acetate was distilled off under reduced pressure from the ethyl acetate layer to obtain about 20 ml of an oily substance.
  • This oily substance was applied to a glass column filled with 200 g of silica gel (Kieselgel 100; manufactured by Merck) and chromatographed by stepwise gradient using chloroform-form methanol as a developing solvent. Separation was performed.
  • This fraction A was purified by high-performance liquid chromatography equipped with YMC J's HERE0DS-H80 (30 mm x 250 mm) [manufactured by YMC Corporation].
  • V (cm: 3485, 2920, 1672, 1615, 1466, 1362, 1080
  • Test example 1 Measurement of hair growth effect using mouse Using 7-week-old male C 3 H mice, experiments were performed according to the method of Ogawa et al. (Normal and Abnormal Epidermal Differrentiation University of Tokyo Press). Three days before the start of the test, the entire back of the mouse was shaved with an electric barren force, and it was confirmed that the back hair of the animal was in a telogen phase. The control group was 10 animals / group, and the other groups were 5 animals.
  • mixture refers to a sample containing compounds 1 to 5 in a weight ratio of 40: 10: 25: 25: 30: 40.
  • Test example 2 Measurement of hair growth effect using mouse
  • mice Using 7-week-old male C 3 H mice, experiments were carried out according to the method of Ogawa et al. (Normal and Abnormal Epidermal Differrent iation Tokyo University Press). Three days before the start of the test, the entire back of the mouse was shaved with an electric barren force, and it was confirmed that the back hair of the animal was in a telogen phase.
  • the control group was 10 animals / group, and the others were 5 animals.
  • About 1501 of this test preparation was applied to the shaved area evenly with a brush twice a day for 5 days / week (after 5 consecutive days of application) No application for 2 days).
  • the animals were observed daily during the test period, and the degree of hair growth was visually evaluated according to the following criteria in six steps, and the average value was determined.
  • the animals were anesthetized on the last day of the test, and the areas of the shaved area and the hair growth area were measured with an image analyzer to determine the ratio of the hair growth area. Tables 3 and 4 show the results.
  • the triprenylphenol derivative obtained from the culture solution of Stachybotrys elegans has an excellent hair-growth effect and is expected to be applied as a hair-growth agent.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

A new hair growth stimulant or hair tonic, i.e. a hair growth activating composition containing one or more triprenylphenol derivatives of general formula (I), salts thereof, and hydrates and solvates of both as the active ingredient, wherein R1 is -H or -CH¿2?CH2OH, R?2¿ is -H or -OH, R3 is -CH=C(CH¿3?)2 or -CH2-COH(CH3)2, and R?4¿ is -H or -OH.

Description

明 細 書 ' 育毛活性組成物 技術分野  Meisho '' Hair Restoration Active Composition Technical Field
本発明は育毛活性組成物に関し、 より詳細には ト リ プレニルフニノ一ル誘導体 を有効成分と して含有する育毛活性組成物に関する。 背景技術  TECHNICAL FIELD The present invention relates to a hair-growth active composition, and more particularly to a hair-growth active composition containing a triprenylphenylninol derivative as an active ingredient. Background art
従来より各種薬剤を配合した育毛、 養毛剤が使用されている。 代表的な有効成 分と しては血流循環改善効果を有するビタ ミ ン E類、 センプリエキスなど、 栄養 補給剤となるア ミ ノ酸と してシスティ ン、 メチォニンなど、 女性ホルモン剤と し てエス トラジオール、 ェチニルェス トラジオ一ルなどが知られており、 これらの 脱毛の様々な原因に対応した複数の薬理作用成分が組み合わされて脱毛症の予防 および治療に用いられている。  Conventionally, hair growth and hair restoration agents containing various chemicals have been used. Representative active ingredients include vitamin E, which has a blood circulation improvement effect, and sempri extract, and female hormones such as cystine and methionine as amino acids that are nutritional supplements. Further, estradiol, ethinyl estradiol and the like are known, and a plurality of pharmacologically active ingredients corresponding to various causes of hair loss are used in combination for the prevention and treatment of alopecia.
これらの育毛、 養毛剤の効果は非常に個人差が大き く 、 新たな育毛、 養毛剤が 求められていた。 発明の開示  The effects of these hair restorer and hair restorer vary greatly between individuals, and new hair restorer and hair restorer were required. Disclosure of the invention
本発明者らは微生物が多様な生理活性物質を生産することに着目 し、 微生物代 謝産物中に育毛活性を有する物質を探索した結果、 スタキボト リ ス属の培養液中 に優れた育毛効果を有する化合物群を見いだし、 本発明を完成するに至った。 すなわち本発明の要旨は、 下記一般式 ( I )  The present inventors have focused on the fact that microorganisms produce a variety of physiologically active substances, and as a result of searching for substances having hair-growth activity in microbial metabolites, have found that an excellent hair-growth effect can be obtained in a culture solution of Stachybotrys. The present inventors have found a group of compounds having the compound, and have completed the present invention. That is, the gist of the present invention is represented by the following general formula (I)
OH 一般式 (; I )
Figure imgf000003_0001
(上記一般式 ( I ) 中、 R1 は— Hまたは一 CH2CH2OHを表し、 ' R2 は一 Hまたは一 0 Hを表し、
OH general formula (; I)
Figure imgf000003_0001
(In the above general formula (I), R 1 represents —H or one CH 2 CH 2 OH, 'R 2 represents one H or one H,
R3 は— CH = C (CH3)2 または— CH2— COH(CH3)2 を表し、 R 3 represents —CH = C (CH 3 ) 2 or —CH 2 —COH (CH 3 ) 2 ,
R4 は— Hまたは— 0Hを表す。 ) R 4 represents —H or —OH. )
で表される ト リ プレニルフヱノ一ル誘導体、 その塩またはそれらの水和物もしく は溶媒和物の 1種または 2種以上を有効成分と して含有する育毛活性組成物に存 する。 Or a salt or a hydrate or solvate thereof as an active ingredient in a hair-growth active composition comprising as an active ingredient a triprenylphenol derivative represented by the formula:
本発明の好ま しい実施の形態と しては、 ト リ プレニルフェノ一ル誘導体が  In a preferred embodiment of the present invention, a triprenyl phenol derivative is used.
Figure imgf000004_0001
Figure imgf000004_0001
Figure imgf000004_0002
Figure imgf000004_0002
Figure imgf000005_0001
Figure imgf000005_0001
Figure imgf000005_0002
Figure imgf000005_0002
のいずれか 1種または 2種以上である育毛活性組成物が挙げられ、 Any one or two or more hair-growth active compositions,
特に ト リ プレニルフヱノ一ル誘導体が、 In particular, triprenylphenol derivatives are
[1] 上記一般式 ( I ) において、 R 1 が— Hであり、 R2 がー Hであり、 R3 が - C H2- C OH (C H3)2 であり、 R4 がー Hである育毛活性組成物、 [1] In the general formula (I), R 1 is —H, R 2 is —H, R 3 is —CH 2 —COH (CH 3 ) 2 , and R 4 is —H A hair-growth active composition,
[2] 上記一般式 ( I ) において、 R 1 がー Hであり、 R2 が— 0 Hであり、 R3 がー CH = C (CH3)2 であり、 R4 が— Hである育毛活性組成物が好ましい。 [2] In the above general formula (I), R 1 is —H, R 2 is —0 H, R 3 is —CH = C (CH 3 ) 2 , and R 4 is —H Hair restoration active compositions are preferred.
また、 ト リ プレニルフヱノール誘導体が ' In addition, the triprenyl phenol derivative is
Figure imgf000006_0001
Figure imgf000006_0001
である育毛活性組成物も、 本発明において好ま しいものと して挙げられる。 The hair-growth active composition is also preferable in the present invention.
また、 本発明の別の実施の形態と しては、 上記一般式 ( I ) において  Further, as another embodiment of the present invention, in the above general formula (I)
[1] R 1 が— Hであり、 R2 が— Hであり、 R3 がー C H 2— C 0 H (C H 3)2 で あり、 R4 がー Hである ト リ プレニルフヱノ一ル誘導体、 その塩またはそれらの 水和物もしく は溶媒和物、 [1] A triprenylphenol derivative in which R 1 is —H, R 2 is —H, R 3 is —CH 2 —C 0 H (CH 3 ) 2 , and R 4 is —H , Its salts or their hydrates or solvates,
[2] R 1 がー Hであり、 R2 が— OHであり、 R3 がー C H = C (CH3)2 であ り、 R 4 が— Hである ト リ プレニルフヱノ一ル誘導体、 その塩またはそれらの水 和物もしく は溶媒和物が挙げられる。 [2] A triprenylphenol derivative in which R 1 is —H, R 2 is —OH, R 3 is —CH CHC (CH 3 ) 2 , and R 4 is —H, Salts or hydrates or solvates thereof are mentioned.
本発明の更に別の実施の形態と しては、  As still another embodiment of the present invention,
[3] スタキボ ト リ ス属に属し、 上記一般式 ( I ) で表される ト リ プレニルフエノ —ル誘導体を生産する能力を有する微生物を培地で培養し、 培養物中に該化合物 を生成蓄積させ、 その培養物から該化合物を採取することを特徴とする上記一般 式 ( I ) で表される 卜 リ ブレニルフヱノ一ル誘導体の製造方法が挙げられる。 スタキボ ト リ ス属に属する微生物を培地で培養し、 培養物中に化合物を生成蓄 積させ、 その培養物から該化合物を採取し、 その物理学的性状に基づき構造解析 した結果、 下記化合物 1 ~ 5の構造を決定した。 化合物 1及び化合物 3は新規な ト リ プレニルフヱノ一ル誘導体であり、 化合物 2及び 5はアイオワ大学の X uら によって抗菌活性物質と して報告されている (J.Org.Chem. 1992, 57, 6700-6703) スタキボ ト リ ン A, Bと一致し、 化合物 4は大正製薬株式会社の折居らによって NG F作用増強物質と して報告されている (特開平 6 - 2 3 9 8 6 9 9号公報) N G F _ 2 4 3 と一致した。 しかしながら、 これら報告文献には育毛活性'に関す る記載はなんらなされていない。 [3] A microorganism belonging to the genus Stachybotrys and capable of producing the triprenyl phenol derivative represented by the above general formula (I) is cultured in a medium, and the compound is produced and accumulated in the culture. And a method for producing a tribrenylphenol derivative represented by the general formula (I), wherein the compound is collected from the culture. A microorganism belonging to the genus Stachybotrys is cultured in a medium, a compound is produced and accumulated in the culture, the compound is collected from the culture, and subjected to structural analysis based on its physical properties. The structure of ~ 5 was determined. Compounds 1 and 3 are novel triprenylphenol derivatives, and compounds 2 and 5 have been reported as antibacterial actives by Xu et al. Of the University of Iowa (J. Org. Chem. 1992, 57, 6700-6703) Consistent with stakibotrins A and B, compound 4 was reported as a NGF action enhancer by Orii et al. Of Taisho Pharmaceutical Co., Ltd. (Japanese Patent Application Laid-Open No. 6-239896999). No.) It was consistent with NGF_2 4 3. However, there is no description of 'hair growth activity' in these reports.
化合物 1 Compound 1
Figure imgf000007_0001
化合物 2 化合物 3
Figure imgf000007_0001
Compound 2 Compound 3
Figure imgf000007_0002
化合物 4
Figure imgf000007_0002
Compound 4
Figure imgf000008_0001
化合物 5
Figure imgf000008_0001
Compound 5
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
上記一般式 ( I ) で表される 卜 リ プレニルフ ノ 一ル誘導体は、 育毛剤、 養毛 剤あるいは脱毛予防、 治療剤の有効成分と して使用することができる。  The triprenyl phenol derivative represented by the above general formula (I) can be used as an active ingredient of a hair restorer, a hair restorer or an agent for preventing or treating hair loss.
上記一般式 ( I ) で表される ト リプレニルフエノ一ル誘導体が形成しう る塩と しては、 例えば、 ナ 卜 リ ゥム塩、 力 リ ウム塩等のアル力 リ金属塩、 マグネシゥム 塩、 カルシウム塩等のアルカ リ土類金属塩、 テ トラメチルアンモニゥム塩等の有 機塩基塩、 アンモニゥム塩等を挙げるこ とができる。 また、 上記一般式 ( I ) で 表される ト リ プレニルフ二ノール誘導体およびその塩は、 水和物または溶媒和物 を形成すること もできる。  Examples of the salt that can be formed by the triprenylphenol derivative represented by the general formula (I) include alkali metal salts such as sodium salts and potassium salts, magnesium salts, magnesium salts, and the like. Examples include alkaline earth metal salts such as calcium salts, organic base salts such as tetramethylammonium salt, and ammonium salts. Further, the triprenyl phenylol derivative represented by the above general formula (I) and a salt thereof can also form a hydrate or a solvate.
次に本発明化合物の製造法につき、 説明する。  Next, the method for producing the compound of the present invention will be described.
上記一般式 ( I ) で表される ト リプレニルフヱノール誘導体は、 スタキボ ト リ ス (Stachybotrys属) に属する微生物により生産することができる。 かかる微生 物と しては、 スタキボ ト リ ス ' エレガンスに属する微生物、 例えばスタキボ ト リ ス ' エレガンス D 1 0 8 7 (Stachybotrys elegans D1087) 等が挙げられる。 ス タキボ ト リ ス ' エレガンス D 1 0 8 7は本発明者らにより天然の土壌より分離さ れた微生物であり、 工業技術院生命工学研究所に F E RM B P— 6 3 7 3と して寄託されている。  The triprenylphenol derivative represented by the above general formula (I) can be produced by a microorganism belonging to Stachybotrys. Examples of such microorganisms include microorganisms belonging to Stachybotrys ′ elegance, such as Stachybotrys elegans D1087. Stakibotris' Elegance D 1 087 is a microorganism isolated from the natural soil by the present inventors and deposited with the Institute of Biotechnology, National Institute of Advanced Industrial Science and Technology as FE RM BP-637 Have been.
尚、 寄託されたスタキボ ト リ ス · エレガンス D 1 0 8 7 (Stachybotrys elega ns D1087) の詳細は下記の通りである。  Details of the deposited Stachybotrys elegance D1087 (Stachybotrys elegans D1087) are as follows.
① 寄託機関の名称 : 国際寄託当局 通商産業省工業技術院生命工学工業技術研 究所 ' あて名 : 日本国茨城県つく ば巿東 1丁目 1番 3号 (郵便番号 3 0 5 - 8 5 6① Depositary institution name: International Depositary Authority Biotechnology Industrial Technology Research Institute, Ministry of International Trade and Industry Tokujo '' Address: 1-3-3 Tsukuba East, Ibaraki, Japan (Zip code: 30-5-856)
6 ) 6)
② 寄託日 : 平成 9年 6月 2 日 (原寄託曰)  ② Deposit date: June 2, 1997 (Hara Deposit)
平成 1 0年 5月 2 5 日に原寄託から上記国際寄託機関への移管の受 領  Receipt of transfer from the original depositary deposit to the above international depositary institution on May 25, 1999
③ 受託番号 : F E RM B P— 6 3 7 3 (平成 9年 6月 2 日に寄託された微ェ 研菌寄第 P - 1 6 2 5 3号より移管)  ③ Accession number: FERMB P-6 3 7 3 (Transferred from P. No. P-162, 53, deposited on June 2, 1997)
ス夕キボ 卜 リ ス ' エレガンス D 1 0 8 7の菌学的性状は以下の通りである。  The mycological properties of Sugi Kibotris' Elegance D 1 087 are as follows.
[形態学的性状]  [Morphological properties]
コロニーの生育は迅速で薄く広がる、 三浦培地(LCA) 上のコロニーは 24°C、 5 日間培養で直径 67mmに達する、 無色、 可溶性色素の生産は認められない。 コロニ —裏面も無色、 通常分生子はほとんど形成しないが、 寒天培地上に滅菌した米粒 を置く ことにより、 その米粒上及び周辺の培地上に大量の分生子が形成される。 ポテ トデキス 卜ロース寒天培地上のコロニー生育は、 24で、 5 日間培養で直径 60mmに達する。 綿毛状、 表面はサーモンピンク色の分生子塊により斑点状に覆わ れる。 コロニー裏面は薄褐色。  Colonies grow rapidly and spread thinly. Colonies on Miura medium (LCA) reach 67 mm in diameter after culturing at 24 ° C for 5 days, producing no colorless and soluble pigment. Colony-The back side is also colorless and usually produces few conidia, but placing sterilized rice grains on agar medium produces a large amount of conidia on the rice grains and on the surrounding medium. Colony growth on potato dextroth agar is 24 and reaches 60 mm in diameter after 5 days of culture. The fluffy surface is covered with spots of salmon conidia. The back of the colony is light brown.
分生子柄は有限、 明確に分化し、 単生あるいは稀に分岐、 直立性でしばしば僅 かに屈曲する、 隔壁数は 2~4、 無色、 表面は平滑、 長さ 74~117(平均 99) m、 幅は基部で 3.8~4.7(平均 3.9) m、 頂端部は先細り し 2.8〜3.4(平均 3.1) m。 フィ アラィ ドは分生子柄頂端部より 3〜7 個が輪生状に生じる、 亜棍棒形、 表 面は平滑、 長さ 10.6〜16.6(平均 13.7) m、 幅 3.4〜5.9(平均 4.3)〃 m。  Conidiophores are finite, well-differentiated, solitary or rarely branched, erect, often slightly bent, number of partitions: 2-4, colorless, surface smooth, length 74-117 (average 99) m, width 3.8-4.7 m (average 3.9 m) at base, tapered 2.8-3.4 m (average 3.1) m at top. Three to seven phyllids are formed in a ring form from the top of the conidiophores, sub-club-shaped, the surface is smooth, 10.6-16.6 (average 13.7) m in length, 3.4-5.9 (average 4.3) in width〃 m.
分生子は頂生、 集合して粘液状の分生子塊を生じる、 無色透明で表面は平滑、 単細胞性、 レモン形ないし紡錘形、 9.4〜12.5(平均 11.0) /urn x 3.8~5.6(平均 4.7) ra 。  Conidia apical, aggregate to produce a viscous conidium mass, colorless and transparent, smooth surface, unicellular, lemon-shaped or spindle-shaped, 9.4-12.5 (average 11.0) / urn x 3.8-5.6 (average 4.7) ra.
分生子は頂生、 フィ ァロ型分生子形成を示し、 フィ アラィ ド頂端で集合して粘 液状の分生子塊を生じる、 単細胞性、 レモン型ないし紡錘形、 無色透明で表面は 平滑、 長さ 9.4~12.5(平均 11.0) / m 、 幅 3.8〜5.6(平均 4.7) m 。  Conidia show apical and filo-type conidium formation, congregate at the apical end of the fiber to produce a viscous conidium mass, unicellular, lemon-shaped or spindle-shaped, colorless and transparent, and the surface is smooth and long. 9.4 ~ 12.5 (average 11.0) / m, width 3.8 ~ 5.6 (average 4.7) m.
テレオモルフは観察されなかつた。 [生理学的性状] ' 生育温度 10°C~35°C(PDA上、 10日間培養) Teleomorph was not observed. [Physiological properties] '' Growth temperature 10 ° C ~ 35 ° C (cultured on PDA for 10 days)
最適生育温度 30。C  Optimal growth temperature 30. C
生育 PH 4~10 (LCA 液体培地上、 10日間培養)  Growth PH 4 ~ 10 (cultured on LCA liquid medium for 10 days)
最適生育 pH 6  Optimal growth pH 6
[分類学的考察]  [Taxonomic considerations]
本菌株 (D1087) は、 1 ) フィ ァ口型分生子を形成する、 2 ) 分生子は明確に 分化、 単生ないし不規則に分岐する、 3 ) 分生子柄上端にフィ アラィ ドを輪生状 に生じる、 4 ) 分生子は求基的に形成され、 フィ アライ ド先端で集合して粘液状 の塊を形成する特徴を有する。 以上の性状より、 本菌株は不完全菌亜門(Deutero mycotina)-不完全糸状菌綱 (Hyphomycetes) の Stachybotrys属に帰属する。  This strain (D1087) has 1) formation of a filamentous conidium, 2) distinct differentiation, solitary or irregular branching, and 3) rotation of a filament at the upper end of the conidiophore. 4) Conidia are formed basophilically and have the characteristic that they aggregate at the ends of the phiride to form a viscous mass. Based on the above properties, this strain belongs to the Stachybotrys genus of the Deutero mycotina-Hyphomycetes class.
S. C. Jong & E. E. Davisによる Stachybotrys属のモノ グラフ(Mycotaxon vol. Ill , (3) 409- 485, 1976)によれば本属には 11種が記載されている。 これらの種は分生 子のサイズ、 形状、 表面構造あるいは色の有無、 分生子形成細胞や分生子柄のサ ィズなどにより識別されている。  According to the monograph of the genus Stachybotrys by S. C. Jong & E. E. Davis (Mycotaxon vol. Ill, (3) 409-485, 1976), there are 11 species in this genus. These species are distinguished by the size, shape, surface structure or color of conidia, the size of conidia-forming cells and conidia, and so on.
同文献の 423〜424 ページの検索表に基づいて本菌株(D1087) の検索を行った と ころ, Stachybotrys elegansと特徴が一致した。 この種は無色の分生子を形成 する点が特徴的であるが、 D1087 も同様に無色の分生子を形成し、 その他分生子 形成器官各部の形態学的特徴ゃコロニ一性状についても Stachybotrys elegansの それとよく一致している。  A search of this strain (D1087) was performed based on the search table on pages 423 to 424 of the same document, and the characteristics were consistent with those of Stachybotrys elegans. This species is characterized by the formation of colorless conidia, but D1087 also forms colorless conidia, and the morphological characteristics of other parts of the conidium-forming organ. ゃ The colony characteristics of Stachybotrys elegans It is in good agreement with it.
なお、 S.C.Jong k E. E. Davisによれば、 本種は S. bisbyiと して扱われているが 、 W. Gams により本種は Stachybotrys elegansシノニムとされている。 (W. Gams , Compendium of Soil Fungi, 1980)。 従って本菌株(D1087) を Stachybotrys el egans .と同定した。  According to S.C.Jongk E.E.Davis, this species is treated as S.bisbyi, but this species is classified as Stachybotrys elegans synonym by W. Gams. (W. Gams, Compendium of Soil Fungi, 1980). Therefore, this strain (D1087) was identified as Stachybotrys elegans.
本発明においては、 前記の菌を通常の微生物が利用しう る栄養物を含有する培 地で培養する。 栄養源と してはグルコース、 水あめ、 デキス ト リ ン、 シュクロ一 ス、 デンプン、 糖蜜、 動 · 植物油等を使用できる。 また窒素源と しては大豆粉、 小麦胚芽、 コーンスティープリ カ一、 綿実柏、 肉エキス、 ペプト ン、 酵母エキス 、 硫酸アンモニゥム、 硝酸ソ一ダ、 尿素等を使用できる。 その他必要に応じて、 ナ ト リ ウム、 カ リ ウム、 カルシウム、 マグネシウム、 コバル ト、 塩素、 リ'ン酸、 硫酸およびその他のィォンを生成することのできる無機塩類を添加することは有 効である。 また、 菌の生育を助け、 ト リ プレニルフエノ一ル誘導体の生産を促進 するような有機および無機塩を適当に添加することができる。 In the present invention, the above bacteria are cultured in a medium containing nutrients that can be used by ordinary microorganisms. As nutrients, glucose, syrup, dextrin, sucrose, starch, molasses, animal and vegetable oils and the like can be used. As the nitrogen source, soybean flour, wheat germ, corn steep liquor, cottonseed birch, meat extract, peptone, yeast extract, ammonium sulfate, sodium nitrate, urea and the like can be used. Other, if necessary, It is beneficial to add sodium, calcium, calcium, magnesium, cobalt, chlorine, phosphoric acid, sulfuric acid and other inorganic salts capable of forming ions. In addition, organic and inorganic salts that assist the growth of the fungus and promote the production of the triprenylphenol derivative can be appropriately added.
本発明における培養法と しては、 好気的条件下での培養法、 特に液体しんと う 培養が最も適している。 培養に適当な温度は、 2 0 °C ~ 3 0 °Cであるが多く の場 合、 2 6 °C〜 2 9 °C付近で培養する。 ト リ プレニルフヱノール誘導体の生産は培 地や培養条件により異なるが、 通常 4 日から 1 0 日の間でその蓄積が最大となる 。 培養物中の ト リ プレニルフエノール誘導体の蓄積量が最大となったときに培養 を停止し、 培養液から目的物質を精製する。  As the culturing method in the present invention, a culturing method under aerobic conditions, particularly a liquid shin culture, is most suitable. The temperature suitable for culturing is 20 ° C to 30 ° C, but in most cases, culturing is performed at around 26 ° C to 29 ° C. The production of the triprenylphenol derivative varies depending on the culture medium and culture conditions, but usually the accumulation is maximum between 4 and 10 days. Stop the culture when the amount of accumulated triprenyl phenol derivative in the culture reaches the maximum, and purify the target substance from the culture solution.
ト リ プレニルフエノ一ル誘導体は脂溶性であるので、 培養物からこれらを精製 する際にはその特性を利用して行う ことができる。 すなわち、 酢酸ェチル、 クロ 口ホルム等による溶媒抽出法、 シリ カゲル、 アルミ ナ、 ォクタデシルシリ カゲル 、 ダイヤイオン H P— 2 0 [三菱化学 (株) 製] 等の合成吸着剤、 またはセファ デッ クス L H — 2 0 [フアルマシア社製] 等のゲル濾過剤等によるカラムクロマ 卜グラフィ一、 さ らにシリ 力ゲル等を担体と した分取クロマ 卜グラフィ一、 場合 によっては各種有機溶媒または水による再結晶等が有効である。  Since the triprenyl phenol derivatives are fat-soluble, they can be purified from cultures by utilizing their properties. That is, a solvent extraction method using ethyl acetate, black form, etc., a synthetic adsorbent such as silica gel, alumina, octadecyl silica gel, Diaion HP-20 (manufactured by Mitsubishi Chemical Corporation), or Sephadex LH-2 0 Column chromatography using a gel filtration agent such as [Pharmacia] etc., and preparative chromatography using a silica gel as a carrier, and in some cases, recrystallization with various organic solvents or water are effective. It is.
本発明の育毛活性組成物と しては、 上記一般式 ( I ) で表される化合物から選 ばれる少なく と も 1種類を含むことが必要であるが、 その使用目的に悪影響を及 ぼさない限り他の活性化合物や添加剤を含めることができる。  The hair-growth active composition of the present invention needs to contain at least one compound selected from the compounds represented by the above general formula (I), but does not adversely affect the purpose of use. As far as possible, other active compounds and additives can be included.
組成物中のこれらの化合物の含有量は、 他の活性化合物及び添加剤との組み合 わせ、 ならびに剤型に応じて変化しうるので限定されるものではない。 しかし、 一般的には総組成物重量あたり 0. 0001〜20重量%、 好ま しく は 0. 01〜5 重量%で ある。  The content of these compounds in the composition is not limited as it can vary according to the combination with other active compounds and additives and the dosage form. However, it is generally from 0.0001 to 20% by weight, preferably from 0.01 to 5% by weight, based on the total composition weight.
限定されるものではないが、 本発明の組成物に加えることのできる他の活性化 合物あるいは添加剤と しては、 化粧品、 医薬部外品、 医薬品に一般に用いられる 各種成分、 例えばポリオキシエチレン ( 8モル) ォレイルアルコールエーテル、 モノォレイ ン酸グリセリル等の油分、 ニコチン酸アミ ド、 ニコチン酸ベンジル、 ビタ ミ ン Eアセテー ト、 センプリ抽出物等の血流促進剤、 グリチルリチン酸、 ヒ ノキチオール等の消炎剤、 ェチニルェス トラジオ一ル等のホルモン類、 i: "夕 ミ ン H、 パン トテニルェチルエーテル等の毛根賦活剤、 モノ ラウ リ ン酸ソルビタ ン、 モノノ、。ルミ チン酸ソルビタ ン、 セスキォレイ ン酸ソルビタ ン、 モノラウ リ ン酸ポ リオキシエチレンソルビタ ン、 ポリエチレングリ コールモノォレコー ト、 ポリオ キシエチレンアルキルエーテル、 ポリ グリ コ一ルジェステル、 ラウ リルジェタノ ールァマイ ド、 脂肪酸イソプロパノ一ルァマイ ド等の非イオン界面活性剤、 パル ミ チン酸ナ ト リ ウム、 ラウ リ ル酸ナ ト リ ウム、 ラウ リ ル硫酸ナ ト リ ウム、 ラウ リ ル硫酸カ リ ウム、 アルキル硫酸 ト リエタノールァミ ン、 口一 卜油、 ロニア ドデシ ルベンゼン硫酸、 ポリオキシエチレン硬化ヒマシ油マレイ ン酸等のァニォン界面 活性剤、 ラウ リルジメチルアミ ンォキサイ ド、 ォレイ ンジメチルアミ ンォキサイ ド等の半極性界面活性剤、 両面活性剤、 保湿剤、 增粘剤、 防腐剤、 酸化防止剤、 香料、 色剤等をあげることができる。 Although not limited, other active compounds or additives that can be added to the composition of the present invention include various components commonly used in cosmetics, quasi-drugs, and pharmaceuticals, such as polyoxygen. Oils such as ethylene (8 mol) oleyl alcohol ether, glyceryl monooleate, etc., blood flow enhancers such as nicotinic acid amide, benzyl nicotinate, vitamin E-acetate, sempli extract, glycyrrhizic acid, Inflammatory agents such as Nokitiol, hormones such as ethinyl estradiol, i: "Hair root activator such as Yumin H, pantothenyl ethyl ether, sorbitan monolaurate, monono, sorbitan luminitate. , Sorbitan sesquioleate, polyoxyethylene sorbitan monolaurate, polyethylene glycol monooleate, polyoxyethylene alkyl ether, polyglycol gester, lauryljetanolamide, fatty acid isopropanolamide, etc. Nonionic surfactants, sodium palmitate, sodium laurate, sodium lauryl sulfate, potassium lauryl sulfate, triethanolamine alkyl sulfate, Oil, Ronia dodecylbenzene sulfate, polyoxyethylene cured Anionic surfactants such as macar oil maleic acid, semi-polar surfactants such as lauryl dimethyl amine oxide and olein dimethyl amine oxide, surfactants, moisturizers, thickeners, preservatives, antioxidants, fragrances And coloring agents.
このような他の活性化合物および添加剤と組み合わされた本発明の育毛活性組 成物は、 その剤型が限定されるものではなく任意であり、 たとえば、 医薬製剤と しては発毛促進および脱毛等の治療剤や予防剤、 化粧品製剤と しては育毛促進お よび脱毛予防効果を有するヘア トニッ ク、 ヘアク リ ーム、 シャ ンプー、 リ ンス等 と して用いることができる。 実施例  The hair-growth active composition of the present invention in combination with such other active compounds and additives is not limited in its dosage form and is optional. For example, as a pharmaceutical preparation, hair growth promotion and It can be used as a therapeutic or preventive agent for hair loss or as a cosmetic preparation, as a hair tonic, hair cream, shampoo, rinse, etc. having a hair growth promoting and hair loss preventing effect. Example
以下実施例により本発明をより具体的に説明するが、 本発明はその要旨を越え ない限り以下の実施例によつて限定されるものではない。  Hereinafter, the present invention will be described more specifically with reference to examples. However, the present invention is not limited to the following examples unless it exceeds the gist of the present invention.
く製造例〉  Production example>
1 ) 培養  1) Culture
種菌培養 : 水あめ 2.0%、 大豆粉 1.0%、 大豆油 0.15%、 サングレイ ン 0.25%、 FeS04 - 7H20 0.0005%、 NiCl 2 · 6H20 0.00005 CaC03 0.1%を含有する培 地 (P H6.0 ) を 4 0 m lずつ 2 0 0 m l三角フラスコ 2本に分注し、 1 2 1 °C において 2 0分間高圧滅菌した。 これにスタキボ ト リ ス · エレガンス D 1 0 8 7 (F E RM B P— 6 3 7 3 ) を 1 白金耳ずっ植菌し、 2 7 °Cで 3日間、 2 1 0 回転にてしんと う培養した。 本培養 : 水あめ 2.0%、 大豆粉 1.0%、 大豆油 0.15%、 サングレイ ン 0: 25%、 FeS04 - 7H20 0.0005%、 NiCl2 · 6H20 0.00005 CaC03 0.1%を含有する培 地 ( p H6.0 ) を 8 0 m l ずつ 5 0 0 m l 三角フラスコ 1 0 0本に分注し、 1 2 1 °Cにおいて 2 0分間高圧滅菌した。 これに種培養液を 0. 4 m 1 ずつ接種し、 2 7 °Cで 8 日間、 2 1 0回転にてしんとう培養した。 Seed culture: syrup 2.0%, soybean meal 1.0%, soybean oil 0.15%, Sangurei down 0.25%, FeS0 4 - 7H 2 0 0.0005%, NiCl 2 · 6H 2 0 0.00005 CaC0 3 culture locations containing 0.1% (P H6 .0) was dispensed into two 200 ml Erlenmeyer flasks in 40 ml aliquots and autoclaved at 121 ° C. for 20 minutes. One platinum loop of Stachybotrys elegance D 1 087 (FE RM BP- 6 3 7 3) was inoculated on this, and the cells were cultured at 27 ° C for 3 days at 210 rpm. . Main culture: syrup 2.0%, soybean meal 1.0%, soybean oil 0.15%, Sangurei emissions 0: 25%, FeS0 4 - 7H 2 0 0.0005%, NiCl 2 · 6H 2 0 0.00005 CaC0 3 culture locations containing 0.1% ( pH 6.0) was dispensed into 100 ml 500 ml Erlenmeyer flasks in 80 ml aliquots and autoclaved at 121 ° C for 20 minutes. This was inoculated with 0.4 ml of a seed culture solution and cultured at 27 ° C. for 8 days at 210 rpm for 8 days.
2 ) 育毛活性組成物の精製 2) Purification of hair growth active composition
上記 1 ) で得られた培養液 5 リ ッ トルにァセ ト ン 5 リ ッ トルを加えて攪拌し、 1 昼夜放置後、 菌体を濾別して抽出液約 9 リ ッ トルを得た。  Five liters of acetone was added to 5 liters of the culture solution obtained in 1), and the mixture was stirred. The mixture was allowed to stand for one day and night, and the bacterial cells were filtered off to obtain about 9 liters of the extract.
得られたアセ ト ン抽出液を減圧下 4 リ ッ トルまで濃縮した。 これを酢酸ェチル 4 リ ッ トルで抽出を行い、 酢酸ェチル層について減圧下酢酸ェチルを留去して、 約 2 0 m 1 の油状物を得た。  The obtained acetate extract was concentrated to 4 liters under reduced pressure. This was extracted with 4 liters of ethyl acetate, and ethyl acetate was distilled off under reduced pressure from the ethyl acetate layer to obtain about 20 ml of an oily substance.
この油状物をシリ 力ゲル (キーゼルゲル 1 0 0 ; メルク社製) 2 0 0 gを充塡 したガラスカラムに付し、 クロ口ホルム メ タノールを展開溶媒と してステップ ワイズグラジェン トによるクロマ ト分離を行った。  This oily substance was applied to a glass column filled with 200 g of silica gel (Kieselgel 100; manufactured by Merck) and chromatographed by stepwise gradient using chloroform-form methanol as a developing solvent. Separation was performed.
シリ カゲルクロマ トグラフィ ーのクロロフオルム/メ タノール 1 0 / 1 溶出画 分を減圧下にて溶媒を留去し、 約 3 0 O m gの画分 Aを得た。  The solvent was distilled off under reduced pressure from the fraction eluted with chloroform / methanol in silica gel chromatography to obtain a fraction A of about 30 Omg.
この画分 Aを YMC J ' s h e r e 0 D S - H 8 0 ( 3 0 mm x 2 5 0 mm) [(株) ヮイエムシィ製] を装着した高速液体ク ロマ ト グラフィ ーにより精 製した。  This fraction A was purified by high-performance liquid chromatography equipped with YMC J's HERE0DS-H80 (30 mm x 250 mm) [manufactured by YMC Corporation].
画分 Aのうち 8 4 m gを 2 m l のメ タノ一ル—水混液 ( 3 : 1 ) に溶解し、 そ のうち 0. 5 m l をメ タノ一ルー水混液 ( 3 : 1 ) で平衡化した分取高速クロマ トグラフィ 一に付した。 メ タノ一ル—水混液 ( 3 : 1 ) を用い毎分 9 m 1 の速さ で溶出した。  Dissolve 84 mg of Fraction A in 2 ml of methanol-water mixture (3: 1) and equilibrate 0.5 ml of it with methanol-water mixture (3: 1) The preparative high-speed chromatography was performed. The mixture was eluted at a rate of 9 ml / min using a methanol-water mixture (3: 1).
分離開始 1 0分後より 1分間に 1 フラ ク ショ ンずつ分取し、 化合物 1 を含有す る画分 B— 1 (フラ ク シ ョ ン 1 3 — 1 4 ) 、 化合物 1を含有する画分 B— 2 (フ ラ ク シ ヨ ン 1 7 ) 、 化合物 3 — 1 を含有する画分 B— 3 (フラ ク シ ョ ン 3 7 ) 、 化合物 3 — 2を含有する画分 B— 4 (フラ ク シ ョ ン 5 0 — 5 1 ) 、 化合物 4 を含 む画分 B— 5 (フラクショ ン 6 5 — 6 6 ) 、 化合物 5を含有するフラク ショ ン ( フラ ク シ ョ ン 7 5 — 7 7 ) を得た。 残りの画分 A溶液に関しても同様に 0. 5 m 1ずつ三回分取ク口マ トグラフィ 一に付し、 それぞれの化合物を含む画 を得、 それぞれをあわせて減圧下溶媒を留去した。 Separate fractions by 1 fraction per minute from 10 minutes after the start of separation. Fractions B-1 (fractions 13-14) containing compound 1 and fractions containing compound 1 Fraction B—2 (fraction 17), fraction B—3 containing compound 3—1 (fraction 37), fraction B—4 containing compound 3—2 (fraction B—4) Fractions 50—51), fractions B—5 containing compound 4 (fractions 65—66), and fractions containing compound 5 (fractions 75—7) 7) was obtained. 0.5 m for the remaining fraction A solution Each fraction was subjected to three times preparative preparative chromatography to obtain a picture containing each compound, and the solvents were distilled off under reduced pressure.
画分 B _ 1 より化合物 1の粗粉末 9. 8 m g、 画分 B— 2より化合物 2の粗粉 末 5. 0 m g、 画分 B— 3より化合物 3— 1の粉末 2. 4 m g、 画分 B— 4より 化合物 3— 2の粉末 2. 2 m g、 画分 B _ 5より化合物 4の粉末 3. 3 m g、 画 分 B— 6より化合物 5の粉末 4. 0 m gを得た。 次に画分 B— 1 より得た化合物 1粗粉末をさ らに高速液体ク口マ トグラフィ 一により精製した。  9.8 mg of crude powder of compound 1 from fraction B_1, 5.0 mg of coarse powder of compound 2 from fraction B-2, 2.4 mg of powder of compound 3-1 from fraction B-3, 2.2 mg of powder of compound 3-2 was obtained from fraction B-4, 3.3 mg of powder of compound 4 was obtained from fraction B_5, and 4.0 mg of powder of compound 5 was obtained from fraction B-6. Next, Compound 1 crude powder obtained from Fraction B-1 was further purified by high performance liquid chromatography.
粗粉末を 0. 5 m 1のメ タ ノ ール一水混液 ( 3 : 1 ) に溶解し、 YMC J ' s h e r e 0 D S - H 8 0 ( 3 0 m m x 2 5 0 m m ) を装着しメ タ ノ ール一 水混液 ( 3 : 2 ) で平衡化した高速液体ク口マ トグラフィ 一に付した。 メ タノー ルー水混液 ( 3 : 2 ) を用い毎分 9 m 1 の速さで溶出し、 分離開始 4 0分後より 1分間に 1 フラク ショ ンずつ分取した。  Dissolve the coarse powder in 0.5 ml of a mixture of methanol and water (3: 1), attach YMC J 'shere 0 DS-H80 (30 mm x 250 mm) High-performance liquid mouth chromatography equilibrated with a mixture of ethanol and water (3: 2) was applied. The mixture was eluted at a rate of 9 ml / min using a mixture of methanol and water (3: 2), and fractionated one fraction per minute from 40 minutes after the start of separation.
化合物 1を含有する画分 C (フラ ク シ ョ ン 3 9— 4 1 ) を減圧下溶媒を留去し 、 化合物 1の粉末 3. 8 m gを得た。 また画分 B— 2より得た化合物 2粗粉末に ついても、 さ らに高速液体ク ロマ ト グラフィ ーにより精製した。  The solvent was distilled off from fraction C (fraction 39-41) containing Compound 1 under reduced pressure to obtain 3.8 mg of Compound 1 powder. Compound 2 crude powder obtained from fraction B-2 was also purified by high performance liquid chromatography.
粗粉末を 0. 4 m 1 のメ タ ノール一水混液 ( 3 : 1 ) に溶解し、 YM C J ' s p h e r e OD S—H 8 0 ( 3 0 m m * 2 5 0 m m ) を装着しメ タ ノ ール一 水混液 ( 1 3 : 7 ) で平衡化した高速液体ク口マ トグラフィ 一に付した。 メ タノ —ルー水混液 ( 1 3 : 7 ) を用い毎分 9 m 1の速さで溶出し、 分離開始 4 0分後 より 1分間に 1 フラク シ ョ ンずつ分取した。  Dissolve the coarse powder in 0.4 ml of a mixture of methanol and water (3: 1), attach YM CJ 'sphere OD S—H80 (30 mm * 250 mm), and add methanol. High-performance liquid chromatography equilibrated with a water-water mixture (13: 7). The mixture was eluted at a rate of 9 ml / min using a methanol-rue water mixture (13: 7), and fractionated one fraction per minute from 40 minutes after the start of separation.
化合物 2を含有する画分 D (フラ ク シ ョ ン 3 8 ) を減圧下溶媒を留去し、 化合 物 2の粉末 1. l mgを得た。  The solvent was distilled off from fraction D (fraction 38) containing compound 2 under reduced pressure to obtain 1.1 mg of compound 2 powder.
同様にして化合物 3— 1〜化合物 5を得た。 得られた化合物 1〜 5の物理的性 状は下記の通りである。 化合物 3 — 1 と化合物 3— 2は立体異性体である。 化合物 1  Similarly, Compounds 3-1 to 5 were obtained. The physical properties of the obtained compounds 1 to 5 are as follows. Compound 3-1 and compound 3-2 are stereoisomers. Compound 1
1 ) 外観 : 白色粉末  1) Appearance: white powder
2 ) 分子量 : 4 0 3  2) Molecular weight: 4 0 3
3 ) 分子式 : C23H33N05 3) Molecular formula: C 23 H 33 N0 5
4 ) E I M S : 4 0 3 (M+ ) 、 3 8 5 [ (M— H20) + ] , 1 7 9 5 ) 高分解能 S I M S : 実測値 3 8 6. 2 3 6 4 4) EIMS: 4 0 3 ( M +), 3 8 5 [(M- H 2 0) +], 1 7 9 5) High-resolution SIMS: actual measured value 3 8 6.2 3 6 4
計算値 3 8 6. 2 3 3 0 [ (M- H20 + H) + ] 6 ) 紫外部吸収スぺク トル : メ タノ ール中 Calculated value 3 8 6. 2 3 3 0 [(M-H 2 0 + H) + ] 6) Ultraviolet absorption spectrum: in methanol
λ m a ( n m) : 303, 254, 214  λma (nm): 303, 254, 214
7 ) 赤外部吸収スペク トル : K B r法 7) Infrared absorption spectrum: KBr method
v ( c m -つ : 3422, 2938, 1672, 1615, 1466, 1362, 1080  v (cm-one: 3422, 2938, 1672, 1615, 1466, 1362, 1080
8 ) 水素核核磁気共鳴スぺク トル : 重メ タ ノ ール中  8) Hydrogen nuclear magnetic resonance spectrum: in heavy metal
<5 p p m : 6.75(1H, s), 5.17(1H, m), 4.26(1H, d, J = 17.7Hz), 4.22(1H, d, J = 17  <5 ppm: 6.75 (1H, s), 5.17 (1H, m), 4.26 (1H, d, J = 17.7 Hz), 4.22 (1H, d, J = 17
.7Hz), 3.88(1H, dd, J=7.0, 5.6Hz), 2.99(1H, dd, J = 17.7, 5.6Hz), 2 .66(1H, dd, J = 17.7, 7. OHz), 1.59(3H, s), 1.28(3H, s), 1.15(6H, s) .7Hz), 3.88 (1H, dd, J = 7.0, 5.6Hz), 2.99 (1H, dd, J = 17.7, 5.6Hz), 2.66 (1H, dd, J = 17.7, 7.OHz), 1.59 (3H, s), 1.28 (3H, s), 1.15 (6H, s)
9 ) 炭素核核磁気共鳴スぺク トル : 重メ タ ノ ール中 9) Carbon nuclear magnetic resonance spectrum: in heavy metal
(5 p p m : 174.25, 157, 96, 150, 19, 136.36, 132.52, 125.48, 124.12, 113.51,  (5 ppm: 174.25, 157, 96, 150, 19, 136.36, 132.52, 125.48, 124.12, 113.51,
100.86, 80.20, 71.39, 68.42, 44.32, 44.20, 41.23, 38.58, 29.17, 2 7.76, 23.69, 22.57, 18.80, 15.78  100.86, 80.20, 71.39, 68.42, 44.32, 44.20, 41.23, 38.58, 29.17, 2 7.76, 23.69, 22.57, 18.80, 15.78
化合物 2 Compound 2
1 ) 外観 : 白色粉末  1) Appearance: white powder
2 ) 分子量 : 4 0 1  2) Molecular weight: 4 0 1
3 ) 分子式 : C 23H31N 05 3) Molecular formula: C 23 H 31 N 0 5
4 ) S I M S : 4 0 2 [ (M + H) + ] 4) SIMS: 402 ([M + H) + ]
5 ) 高分解能 S I MS : 実測値 4 0 2 2 2 9 8 5) High resolution S I MS: measured value 4 0 2 2 2 9 8
計算値 4 0 2 2 2 7 9 [ (M + H) + ] Calculated value 4 0 2 2 2 7 9 [(M + H) + ]
6 ) 紫外部吸収スぺク トル : メ タ ノール中  6) Ultraviolet absorption spectrum: in methanol
λ m a X ( n m) : 303, 254, 214  λmaX (nm): 303, 254, 214
7 ) 赤外部吸収スぺク トル : K B r法  7) Infrared absorption spectrum: KBr method
V ( c mーリ :  V (cmuri:
8 ) 水素核核磁気共鳴スぺク トル : 重メ タノール中  8) Hydrogen nuclear magnetic resonance spectrum: in heavy methanol
5 p p m : 6.75 (1H, s), 5.31 (1H, m), 5.09 (brs), 4.25 (2H, brs), 4.07 (2H, m),  5 p p m: 6.75 (1H, s), 5.31 (1H, m), 5.09 (brs), 4.25 (2H, brs), 4.07 (2H, m),
3.89(1H, dd, J=7.0, 5.6Hz), 2.99(1H, dd, J = 17.7, 5.6Hz), 2.66(1H , dd, J = 17.7, 7. OHz), 1.64 (3H, s), 1.57 (3H, s), 1.28(3H, s) 9 ) 炭素核核磁気共鳴スペク トル :重メ タノ ール中 '3.89 (1H, dd, J = 7.0, 5.6Hz), 2.99 (1H, dd, J = 17.7, 5.6Hz), 2.66 (1H, dd, J = 17.7, 7.OHz), 1.64 (3H, s), 1.57 (3H, s), 1.28 (3H, s) 9) Carbon nuclear magnetic resonance spectrum: in heavy methanol
5 p p m : 174.25, 157, 99, 150, 13, 139.79, 132.55, 132.28, 128, 87, 125.43, 5 ppm: 174.25, 157, 99, 150, 13, 139.79, 132.55, 132.28, 128, 87, 125.43,
124.11, 113.51, 100.91, 80.15, 68.35, 59.85, 44.20, 38.90, 36.02 , 27.92, 27.75, 25.84, 22.19, 18.77, 17.75  124.11, 113.51, 100.91, 80.15, 68.35, 59.85, 44.20, 38.90, 36.02, 27.92, 27.75, 25.84, 22.19, 18.77, 17.75
化合物 3 - 1 Compound 3-1
1 ) 外観 : 白色粉末  1) Appearance: white powder
2 ) 分子量 : 4 0 1  2) Molecular weight: 4 0 1
3 ) 分子式 : C 23H31N 05 3) Molecular formula: C 23 H 31 N 0 5
4 ) S I M S : 4 0 2 [ (M + H) + ] 、 3 8 4 [ (M- H20 + H) + ] 5 ) 高分解能 S I M S : 実測値 4 0 2 2 3 0 0 4) SIMS: 4 0 2 [ (M + H) +], 3 8 4 [(M- H 2 0 + H) +] 5) High resolution SIMS: Found 4 0 2 2 3 0 0
計算値 4 0 2 2 2 7 9 [ (M + H) + ]  Calculated value 4 0 2 2 2 7 9 [(M + H) +]
6 ) 紫外部吸収スぺク トル : ァセ トニ ト リ ル中  6) Ultraviolet absorption spectrum: in acetonitrile
λ m a X ( n m) : 300, 259, 214  λmaX (nm): 300, 259, 214
7 ) 赤外部吸収スぺク トル: K B r法  7) Infrared absorption spectrum: KBr method
V ( c m— 1) : 3424, 2924, 1672, 1618, 1460, 1352, 1082, 1034 V (cm— 1 ): 3424, 2924, 1672, 1618, 1460, 1352, 1082, 1034
8 ) 水素核核磁気共鳴スぺク トル :重ァセ トニト リル中  8) Hydrogen nuclear magnetic resonance spectrum: in heavy acetonitrile
<5 p p m : 6.87(1H, brs), 6.60 (IH, s), 5.84 (IH, brs), 5.13 (IH, m), 5.08 (IH, m), 3.86(1H, dd, J=6.4, 5.1Hz), 2.89(1H, dd, J = 17.6, 5.6Hz), 2.57 (IH, dd, J = 17.6, 6.4Hz), 1.65 (3H. s), 1.59(3H, s), 1.57(3H, s), 1. 26(3H, s)  <5 ppm: 6.87 (1H, brs), 6.60 (IH, s), 5.84 (IH, brs), 5.13 (IH, m), 5.08 (IH, m), 3.86 (1H, dd, J = 6.4, 5.1 Hz), 2.89 (1H, dd, J = 17.6, 5.6Hz), 2.57 (IH, dd, J = 17.6, 6.4Hz), 1.65 (3H.s), 1.59 (3H, s), 1.57 (3H, s ), 1.26 (3H, s)
9 ) 炭素核核磁気共鳴スぺク トル :重ァセ トニト リル中  9) Carbon nuclear magnetic resonance spectrum: in heavy acetonitrile
<5 p p m : 169.93, 158.04, 150, 98, 136.18, 132.56, 132.18, 125.46, 125.26,  <5 ppm: 169.93, 158.04, 150, 98, 136.18, 132.56, 132.18, 125.46, 125.26,
113.21, 100.55, 79.92, 77.69, 67.54, 40.35.38.11, 27.43, 27.40, 25.78, 22.20, 19, 13, 17.74, 16.03  113.21, 100.55, 79.92, 77.69, 67.54, 40.35.38.11, 27.43, 27.40, 25.78, 22.20, 19, 13, 17.74, 16.03
化合物 3 - 2 Compound 3-2
1 ) 外観 : 白色粉末  1) Appearance: white powder
2 ) 分子量 : 4 0 1  2) Molecular weight: 4 0 1
3 ) 分子式: C 23H31N 05 3) Molecular formula: C 23 H 31 N 0 5
4 ) S I M S : 4 0 2 [ (M + H) + ] 、 3 8 4 [ (M- H20 + H) + ] 5 ) 高分解能 S I MS : 実測値 4 0 2. 2 2 5 2 ' 4) SIMS: 4 0 2 [ (M + H) +], 3 8 4 [(M- H 2 0 + H) +] 5) High resolution SI MS: actual measured value 4 0 2.2 2 5 2 '
計算値 4 0 2. 2 2 7 9 [ (M + H) + ] Calculated value 4 0 2.2 2 7 9 [(M + H) + ]
6 ) 紫外部吸収スぺク トル : ァセ トニ ト リ ル中 6) Ultraviolet absorption spectrum: in acetonitrile
λ m a X ( n m) : 300, 259, 214  λmaX (nm): 300, 259, 214
7 ) 赤外部吸収スペク トル : K B r法 7) Infrared absorption spectrum: KBr method
v ( c m一1) : 3399, 2924, 1692, 1618, 1460, 1360, 1078 v (cm- 1 ): 3399, 2924, 1692, 1618, 1460, 1360, 1078
8 ) 水素核核磁気共鳴スぺク 卜ル : 重ァセ トニ ト リル中  8) Nuclear nuclear magnetic resonance spectrum: heavy acetonitrile
<5 p p m : 6.88(1H, brs), 6.60 (IH, s), 5.84(1H, brs), 5.14 (IH, m), 5.07 (IH, m), 3.85(1H, dd, J=6.5, 5.4Hz), 2.89 (IH, dd, J = 17.6, 5.4Hz), 2.56 (IH, dd, J = 17.6, 6.5Hz), 1.64 (3H, s), 1.57(3H, s), 1.56(3H, s), 1. <5 ppm: 6.88 (1H, brs), 6.60 (IH, s), 5.84 (1H, brs), 5.14 (IH, m), 5.07 (IH, m), 3.85 (1H, dd, J = 6.5, 5.4 Hz), 2.89 (IH, dd, J = 17.6, 5.4Hz), 2.56 (IH, dd, J = 17.6, 6.5Hz), 1.64 (3H, s), 1.57 (3H, s), 1.56 (3H, s ), 1.
26(3H, s) 26 (3H, s)
9 ) 炭素核核磁気共鳴スぺク トル : 重ァセ トニ ト リル中  9) Carbon nuclear magnetic resonance spectrum: in heavy acetonitrile
5 p p m : 169.94, 158.02, 151.01, 136.11, 132.53, 132.19, 125.42, 125.24,  5 ppm: 169.94, 158.02, 151.01, 136.11, 132.53, 132.19, 125.42, 125.24,
125.21, 113.40, 100.62, 79.96, 77.71, 67.59, 40.33, 37.99, 27.49 , 27.37, 25.77, 22.24, 19, 06, 17.72, 15.94  125.21, 113.40, 100.62, 79.96, 77.71, 67.59, 40.33, 37.99, 27.49, 27.37, 25.77, 22.24, 19, 06, 17.72, 15.94
化合物 4 Compound 4
1 ) 外観 : 白色粉末  1) Appearance: white powder
2 ) 分子量 : 4 2 9  2) Molecular weight: 4 2 9
3 ) 分子式 : C 25H35N 05 3) Molecular formula: C 25 H 35 N 0 5
4 ) S I M S : 4 3 0 [ (M + H) + ] 4) SIMS: 4 3 0 [(M + H) + ]
5 ) 高分解能 S I M S : 実測値 4 3 0 2 5 8 3  5) High resolution S I M S: Actual value 4 3 0 2 5 8 3
計算値 4 3 0 2 5 9 1 [ (M + H) + ]  Calculated value 4 3 0 2 5 9 1 [(M + H) +]
6 ) 紫外部吸収スぺク トル : メ タ ノ ール中  6) Ultraviolet absorption spectrum: in the middle of methanol
λ m a X ( n m) : 305, 258, 215  λmaX (nm): 305, 258, 215
7 ) 赤外部吸収スペク トル : K B r法 7) Infrared absorption spectrum: KBr method
v ( c m—リ : 3424, 2924, 1655, 1618, 1460, 1078  v (cm-li: 3424, 2924, 1655, 1618, 1460, 1078
8 ) 水素核核磁気共鳴スぺク トル : 重メ タノ一ル中  8) Hydrogen nuclear magnetic resonance spectrum: in heavy methanol
δ p p m : 6.74 (IH, s), 5.15 (IH, m), 5.07(lH(ra), 4.42 (IH, d, J = 17.2Hz), 4.3 δ ppm: 6.74 (IH, s), 5.15 (IH, m), 5.07 (lH ( ra), 4.42 (IH, d, J = 17.2Hz), 4.3
9(1H, d, J = 17.2Hz), 3.88(1H, dd, J=7.0, 5.5Hz), 3.78(2H, t, J = 5.2 Hz), 3.68(2H, t, J=5.2Hz), 2.98(1H, dd, J = 17.6, 5.5Hz), 2.65(1H, dd, J = 17.6, 7. OHz), 1.64 (3H, s), 1.59(3H, s), 1.57(3H, s), 1.27(3 H, s) 9 (1H, d, J = 17.2Hz), 3.88 (1H, dd, J = 7.0, 5.5Hz), 3.78 (2H, t, J = 5.2 Hz), 3.68 (2H, t, J = 5.2Hz), 2.98 (1H, dd, J = 17.6, 5.5Hz), 2.65 (1H, dd, J = 17.6, 7.OHz), 1.64 (3H, s) , 1.59 (3H, s), 1.57 (3H, s), 1.27 (3H, s)
9 ) 炭素核核磁気共鳴スぺク トル :重メ タ ノ ール中  9) Carbon nuclear magnetic resonance spectrum: in heavy metal
5 p p m: 171.54, 157, 96, 149.93, 136.24, 132.82, 132.17, 125.49, 125.37,  5 ppm: 171.54, 157, 96, 149.93, 136.24, 132.82, 132.17, 125.49, 125.37,
122.02, 113.28, 100.85, 80.19, 68.43, 61.26, 50.14, 46.29, 40.81 , 38.61, 27.76, 27.73, 25.84, 22.57, 18.77, 17.72, 15.95 化合物 5  122.02, 113.28, 100.85, 80.19, 68.43, 61.26, 50.14, 46.29, 40.81, 38.61, 27.76, 27.73, 25.84, 22.57, 18.77, 17.72, 15.95 Compound 5
1 ) 外観: 白色粉末  1) Appearance: White powder
2 ) 分子量 : 3 8 5 2) Molecular weight: 3 8 5
3 ) 分子式 : C23H31N04 3) Molecular formula: C 23 H 31 N0 4
4 ) S I MS : 3 8 6 [ (M + H) + ] 4) SI MS: 3 8 6 [(M + H) + ]
5 ) 高分解能 S I MS :実測値 3 8 6 2 3 6 6  5) High resolution S I MS: actual measured value 3 8 6 2 3 6 6
計算値 3 8 6 2 3 3 0 [ (M + H) ]  Calculated value 3 8 6 2 3 3 0 [(M + H)]
6 ) 紫外部吸収スペク トル : メ タノ ール中 6) Ultraviolet absorption spectrum: in methanol
λ m a ( n m) : 302, 255, 214  λm a (n m): 302, 255, 214
7 ) 赤外部吸収スぺク トル : K B r法  7) Infrared absorption spectrum: KBr method
V ( cm リ : 3485, 2920, 1672, 1615, 1466, 1362, 1080  V (cm: 3485, 2920, 1672, 1615, 1466, 1362, 1080
8 ) 水素核核磁気共鳴スぺク トル :重メ タノ ール中  8) Hydrogen nuclear magnetic resonance spectrum: in heavy methanol
5 p p m: 6.75 (IH, s), 5.15 (IH, m), 5.06 (IH, m), 4.26 (IH, d, J = 17.7Hz), 4.2  5 p p m: 6.75 (IH, s), 5.15 (IH, m), 5.06 (IH, m), 4.26 (IH, d, J = 17.7 Hz), 4.2
2(1H, d, J = 17.7Hz), 3.88 (IH, dd, J=7.0, 5.6Hz), 2.98 (IH, dd, J = 17 .6, 5.6Hz), 2.66(1H, dd, J = 17.6, 7. OHz), 1.63(3H, s), 1.58(3H, s) , 1.56C3H, s), 1.28C3H, s)  2 (1H, d, J = 17.7Hz), 3.88 (IH, dd, J = 7.0, 5.6Hz), 2.98 (IH, dd, J = 17.6, 5.6Hz), 2.66 (1H, dd, J = 17.6, 7.OHz), 1.63 (3H, s), 1.58 (3H, s), 1.56C3H, s), 1.28C3H, s)
9 ) 炭素核核磁気共鳴スぺク トル :重メ タ ノ ール中  9) Carbon nuclear magnetic resonance spectrum: in heavy metal
(5 p p m : 174.26, 157, 97, 150, 20, 136.19, 132.51, 132.17, 125.51, 125.36,  (5 ppm: 174.26, 157, 97, 150, 20, 136.19, 132.51, 132.17, 125.51, 125.36,
124.12, 113.50, 100.86, 80.20, 68.42, 44.20, 40.80, 38.52, 27.78 , 27.71, 25.83, 22.58, 18.84, 17.70, 15.89  124.12, 113.50, 100.86, 80.20, 68.42, 44.20, 40.80, 38.52, 27.78, 27.71, 25.83, 22.58, 18.84, 17.70, 15.89
く試験例〉  Test example>
試験例 1 : マウスを用いた育毛効果の測定 7週齢の雄性 C 3 Hマウスを用い、 小川らの方法 (Normal and Abnormal Epid ermal Differrentiation 東大出版会) に従い、 実験を行った。 試験開始 3 日前 にマウスの全背部を電気バリ力ンで刈毛し、 動物の背部毛が休止期にあることを 確認した。 対照群は 1 0匹/群と し、 他は 5匹ノ群と した。 Test example 1: Measurement of hair growth effect using mouse Using 7-week-old male C 3 H mice, experiments were performed according to the method of Ogawa et al. (Normal and Abnormal Epidermal Differrentiation University of Tokyo Press). Three days before the start of the test, the entire back of the mouse was shaved with an electric barren force, and it was confirmed that the back hair of the animal was in a telogen phase. The control group was 10 animals / group, and the other groups were 5 animals.
サンプルは乾燥物 1 5 O m gをエタノール : プロピレングリ コール = 8 : 2の 溶液 1 5 0 m l に溶解して試験製剤と した。 この試験製剤約 1 5 0 1 を 1 日 2 回ずつ、 5 日ノ週で刈毛部に刷毛で均一に塗布した ( 5 日連続で塗布した後 2 日 間は無塗布の繰り返し) 。 試験期間中毎日動物を観察し、 以下の基準に従い目視 により発毛程度を 6段階評価し、 平均値を求めた。 また、 試験最終日に動物を麻 酔し、 刈毛域と発毛域の面積を画像解析装置で測定し、 発毛部の比率を求めた。 その結果を表 1 、 2 に示す。  The sample was prepared by dissolving 15 mg of dried matter in 150 ml of a solution of ethanol: propylene glycol = 8: 2. About 1501 of this test preparation was applied twice a day to the shaved area evenly with a brush twice a day for 5 days (the application was repeated for 5 consecutive days and then repeated for 2 days). The animals were observed daily during the test period, and the degree of hair growth was visually evaluated according to the following criteria in six steps, and the average value was determined. In addition, the animals were anesthetized on the last day of the test, and the areas of the shaved area and the hair growth area were measured with an image analyzer to determine the ratio of the hair growth area. The results are shown in Tables 1 and 2.
0 : 全く生えていない  0: Not growing at all
1 : わずかに生えている  1: Slightly growing
2 : 〜1/3 生えている  2: growing up to 1/3
3 : 1/3 〜2/3 生えている  3: 1/3 to 2/3 are growing
4 : 2/3 〜ほとんど生えている  4: 2/3-almost growing
5 : 全部生えている  5: All are growing
なお表 1 および表 2中、 混合物とは化合物 1 ~ 5をそれぞれ重量比にして 4 0 : 1 0 : 2 5 : 2 5 : 3 0 : 4 0ずつ含有するサンプルを示す。 In Tables 1 and 2, the term “mixture” refers to a sample containing compounds 1 to 5 in a weight ratio of 40: 10: 25: 25: 30: 40.
表 1 table 1
Figure imgf000020_0001
Figure imgf000020_0001
表 2 Table 2
Figure imgf000020_0002
Figure imgf000020_0002
試験例 2 : マウスを用いた育毛効果の測定 Test example 2: Measurement of hair growth effect using mouse
7週齢の雄性 C 3 Hマウスを用い、 小川らの方法 (Normal and Abnormal Epid ermal D i f f errent iat ion 東大出版会) に従い、 実験を行った。 試験開始 3 日前 にマウスの全背部を電気バリ力ンで刈毛し、 動物の背部毛が休止期にあることを 確認した。 対照群は 1 0匹/群と し、 他は 5匹ノ群と した。  Using 7-week-old male C 3 H mice, experiments were carried out according to the method of Ogawa et al. (Normal and Abnormal Epidermal Differrent iation Tokyo University Press). Three days before the start of the test, the entire back of the mouse was shaved with an electric barren force, and it was confirmed that the back hair of the animal was in a telogen phase. The control group was 10 animals / group, and the others were 5 animals.
供試サンプルは各々表 3記載の濃度になるように、 エタノール : プロピレング リ コール = 8 : 2の溶液 1 0 0 m l に溶解した。 この試験製剤約 1 5 0 1 を 1 日 2回ずつ、 5 日/週で刈毛部に刷毛で均一に塗布した ( 5 日連続で塗布した後 2 日間は無塗布の繰り返し) 。 試験期間中毎日動物を観察し、 以下の基準に従い 目視により発毛程度を 6段階評価し、 平均値を求めた。 また、 試験最終日に動物 を麻酔し、 刈毛域と発毛域の面積を画像解析装置で測定し、 発毛部の比率を求め た。 その結果を表 3、 4 に示す。 The test samples were dissolved in 100 ml of a solution of ethanol: propylene glycol = 8: 2 so as to have the concentrations shown in Table 3, respectively. About 1501 of this test preparation was applied to the shaved area evenly with a brush twice a day for 5 days / week (after 5 consecutive days of application) No application for 2 days). The animals were observed daily during the test period, and the degree of hair growth was visually evaluated according to the following criteria in six steps, and the average value was determined. In addition, the animals were anesthetized on the last day of the test, and the areas of the shaved area and the hair growth area were measured with an image analyzer to determine the ratio of the hair growth area. Tables 3 and 4 show the results.
0 全く生えていない  0 Not growing at all
1 わずかに生えている  1 Slightly growing
2 〜1/3 生えている  2 to 1/3 growing
3 1/3 〜2/3 生えている  3 1/3 to 2/3
4 2/3 〜ほとんど生えている  4 2/3-Almost growing
5 全部生えている  5 All are growing
なお、 表 3、 4中、 ノキシジルは、 シグマ社より購入した。 表 3  In Tables 3 and 4, noxidil was purchased from Sigma. Table 3
Figure imgf000021_0001
Figure imgf000021_0001
氺 W / W 表 4 氺 W / W Table 4
Figure imgf000022_0001
Figure imgf000022_0001
産業上の利用可能性 Industrial applicability
スタキボ 卜 リス ' ェレガンスの培養液中より得られた ト リ プレニルフヱノ一ル 誘導体は優れた育毛効果を有しており、 育毛剤としての応用が期待される。  The triprenylphenol derivative obtained from the culture solution of Stachybotrys elegans has an excellent hair-growth effect and is expected to be applied as a hair-growth agent.

Claims

請 求 の 範 囲 The scope of the claims
1. 下記一般式 ( I ) 1. The following general formula (I)
0H 一般式 ( I )
Figure imgf000023_0001
0H General formula (I)
Figure imgf000023_0001
(上記一般式 ( I ) 中、 R' は一 Hまたは— CH2CH2OHを表し、 (In the above general formula (I), R ′ represents 1 H or —CH 2 CH 2 OH,
R2 は一 Hまたは— 0Hを表し、 R 2 represents 1 H or — 0H,
R3 は一 CH = C (CH3)2 または一 CH2_ C〇H(CH3)2 を表し、 R 3 represents one CH = C (CH 3 ) 2 or one CH 2 _C〇H (CH 3 ) 2 ;
R4 は— Hまたは— 0 Hを表す。 ) R 4 represents —H or —0H. )
で表される ト リ プレニルフエノール誘導体、 その塩またはそれらの水和物もしく は溶媒和物の 1種または 2種以上を有効成分と して含有する育毛活性組成物。 A hair-growth active composition comprising, as an active ingredient, one or more of a triprenyl phenol derivative represented by the following formula, a salt thereof, or a hydrate or solvate thereof.
2. ト リ プレニルフヱ ノ ール誘導体が 2. The triprenylphenol derivative is
Figure imgf000023_0002
Figure imgf000023_0002
Figure imgf000024_0001
Figure imgf000024_0002
Figure imgf000024_0001
Figure imgf000024_0002
Figure imgf000024_0003
Figure imgf000024_0003
のいずれか 1種または 2種以上である請求の範囲第 1項記載の育毛活性組成物 ( Any one or two or more at which hair growth active composition range first claim of claim of (
3. ト リ プレニルフヱノ一ル誘導体が 3. The triprenylphenol derivative is
Figure imgf000025_0001
Figure imgf000025_0001
である請求の範囲第 1項または第 2項記載の育毛活性組成物。 3. The hair-growing active composition according to claim 1 or 2, which is:
4. R 1 が— Hであり、 R2 が— Hであり、 R3 がー CH2— C OH (C H3)2 であり、 R4 がー Hである請求の範囲第 1項記載の育毛活性組成物。 4. The method according to claim 1, wherein R 1 is —H, R 2 is —H, R 3 is —CH 2 —COH (CH 3 ) 2 , and R 4 is —H. Hair restoration active composition.
5. R 1 が— Hであり、 R2 がー OHであり、 R3 が— CH = C (CH3)2 で あり、 R4 が- Hである請求の範囲第 1項記載の育毛活性組成物。 5. The hair-growth activity according to claim 1, wherein R 1 is —H, R 2 is —OH, R 3 is —CH = C (CH 3 ) 2 , and R 4 is —H. Composition.
6. スタキボ ト リ ス属に属し、 下記一般式 ( I ) で表される ト リ プレニルフエ ノール誘導体を生産する能力を有する微生物を培地で培養し、 培養物中に該化合 物を生成蓄積させ、 その培養物から該化合物を採取することを特徴とする下記一 般式 ( I ) で表される ト リ プレニルフヱノール誘導体の製造方法。  6. A microorganism belonging to the genus Stachybotrys and capable of producing a triprenylphenol derivative represented by the following general formula (I) is cultured in a medium, and the compound is produced and accumulated in the culture. A method for producing a triprenylphenol derivative represented by the following general formula (I), wherein the compound is collected from the culture.
'般式 ( I )
Figure imgf000025_0002
'General formula (I)
Figure imgf000025_0002
(上記一般式 ( I ) 中、 R1 は一 Hまたは— CH2CH2OHを表し、 (In the above general formula (I), R 1 represents 1 H or —CH 2 CH 2 OH,
R 2 は _ Hまたは— 0 Hを表し、 R 2 represents _ H or — 0 H,
R3 は一 CH = C (CH3)2 または一 CH2— C OH(CH3)2 を表し R4 は— Hまたは—OHを表す。 ) R 3 represents one CH = C (CH 3 ) 2 or one CH 2 —C OH (CH 3 ) 2 R 4 represents —H or —OH. )
7. R 1 がー Hであり、 R2 が— Hであり、 R3 が— CH2— C OH(CH3)2 であり、 R4 がー Hである請求の範囲第 6項記載の製造方法。 7. The method according to claim 6, wherein R 1 is —H, R 2 is —H, R 3 is —CH 2 —COH (CH 3 ) 2 , and R 4 is —H. Production method.
8. R 1 がー Hであり、 R2 がー OHであり、 R3 がー CH = C (CH3)2 で あり、 R4 が- Hである請求の範囲第 6項記載の製造方法。 8. The method according to claim 6, wherein R 1 is -H, R 2 is -OH, R 3 is -CH = C (CH 3 ) 2 , and R 4 is -H. .
OH 一般式 ( I )
Figure imgf000026_0001
OH general formula (I)
Figure imgf000026_0001
上記一般式 ( I ) 中、 R1 がー Hであり、 R2 が— Hであり、 R3 が _ CH2_ C 0 H (C H 3 ) 2 であり、 R4 がー Hである ト リプレニルフヱノール誘導体、 そ の塩またはそれらの水和物もしく溶媒和物。 In the general formula (I), R 1 is -H, R 2 is -H, R 3 is _CH 2 _C 0 H (CH 3) 2, and R 4 is -H. Riprenyl phenol derivative, its salt or hydrate or solvate thereof.
1 0 OH 一般式 ( I )
Figure imgf000026_0002
10 0 OH General formula (I)
Figure imgf000026_0002
上記一般式 ( I ) 中、 R1 が—Hであり、 R2 が— 0Hであり、 R3 が— C H = C (C H 3 ) 2 であり、 R4 がー Hである トリプレニルフヱノ一ル誘導体、 その塩 またはそれらの水和物もしく溶媒和物。 In the above general formula (I), R 1 is —H, R 2 is —0H, R 3 is —CH = C (CH 3) 2, and R 4 is —H. Nol derivatives, their salts or hydrates or solvates thereof.
PCT/JP1998/002525 1997-06-09 1998-06-08 Hair growth activating composition WO1998056940A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9/150702 1997-06-09
JP15070297 1997-06-09

Publications (1)

Publication Number Publication Date
WO1998056940A1 true WO1998056940A1 (en) 1998-12-17

Family

ID=15502558

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1998/002525 WO1998056940A1 (en) 1997-06-09 1998-06-08 Hair growth activating composition

Country Status (1)

Country Link
WO (1) WO1998056940A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047478A2 (en) * 1999-12-24 2001-07-05 Henkel Kommanditgesellschaft Auf Aktien Enzymatic dye
WO2007111203A1 (en) 2006-03-27 2007-10-04 Tokyo University Of Agriculture And Technology Tlo Co., Ltd. Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
JP5952257B2 (en) * 2011-02-24 2016-07-13 株式会社ティムス Soluble epoxide hydrolase inhibitor
US11440920B2 (en) 2018-11-02 2022-09-13 Showa University Chemical method of producing SMTP groups or SMTP-7 and intermediates used in the method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06239869A (en) * 1993-02-17 1994-08-30 Taisho Pharmaceut Co Ltd Ngf action enhancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06239869A (en) * 1993-02-17 1994-08-30 Taisho Pharmaceut Co Ltd Ngf action enhancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOHYAMA T., ET AL.: "SMTP-1 AND -2, NOVEL ANALOGS OF STAPLABIN PRODUCED BY STACHYBOTRYS MICROSPORA IFO30018.", THE JOURNAL OF ANTIBIOTICS, NATURE PUBLISHING GROUP, GB, vol. 50., no. 02., 1 January 1997 (1997-01-01), GB, pages 172 - 174., XP002912281, ISSN: 0021-8820 *
XU X., ET AL.: "STACHYBOTRINS A AND B: NOVEL BIOACTIVE METABOLITES FROM A BRACKISH WATER ISOLATE OF THE FUNGUS STACHYBOTRYS SP.", JOURNAL OF ALLOYS AND COMPOUNDS., ELSEVIER SEQUOIA, LAUSANNE., CH, vol. 57., 1 January 1992 (1992-01-01), CH, pages 6700 - 6703., XP002914290, ISSN: 0925-8388 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047478A2 (en) * 1999-12-24 2001-07-05 Henkel Kommanditgesellschaft Auf Aktien Enzymatic dye
WO2001047478A3 (en) * 1999-12-24 2002-01-10 Henkel Kgaa Enzymatic dye
WO2007111203A1 (en) 2006-03-27 2007-10-04 Tokyo University Of Agriculture And Technology Tlo Co., Ltd. Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
EP2000540A2 (en) * 2006-03-27 2008-12-10 Tokyo University of Agriculture and Technology TLO Co., Ltd. Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
EP2000540A4 (en) * 2006-03-27 2011-11-30 Univ Tokyo Agriculture & Technology Tlo Co Ltd Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
US8110596B2 (en) 2006-03-27 2012-02-07 Tokyo University Of Agriculture And Technology Tlo Co., Ltd. Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
EP2508611A1 (en) 2006-03-27 2012-10-10 Tokyo University of Agriculture and Technology TLO Co., Ltd. Process for production of triprenyl phenol compounds
EP2604697A1 (en) * 2006-03-27 2013-06-19 Tokyo University of Agriculture and Technology TLO Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer
CN102304131B (en) * 2006-03-27 2014-07-16 农工大Tlo株式会社 Triprenyl phenol compound and its preparing method, and thrombolysis enhancer
US8883462B2 (en) 2006-03-27 2014-11-11 Tokyo University Of Agriculture And Technology Tlo Co., Ltd. Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
CN102321092B (en) * 2006-03-27 2015-01-14 农工大Tlo株式会社 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
JP5952257B2 (en) * 2011-02-24 2016-07-13 株式会社ティムス Soluble epoxide hydrolase inhibitor
US11440920B2 (en) 2018-11-02 2022-09-13 Showa University Chemical method of producing SMTP groups or SMTP-7 and intermediates used in the method

Similar Documents

Publication Publication Date Title
Hur et al. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein
JPH09505567A (en) Polycyclic anthelmintic drug, method and strain for producing the same, and use thereof
JP2000503627A (en) Compounds extracted from plants of the genus Comifora, especially Comifora moocal, extracts containing the compounds, and their use in cosmetics and the like
JPS6357591A (en) Novel compound, manufacture and medicinal composition
KR20150083290A (en) Method for preparing ginsenoside derivative and composition comprising ginsenoside derivative prepared by the same for whitening and improving wrinkle
KR102107194B1 (en) Cosmetic Composition For Preventing Hair Loss Containing Arctium Lappa Seed Extract
DE3832362A1 (en) NEW CYCLOPEPTOLIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE
US6303350B1 (en) Physiologically active substances TKR2449, process for producing the same, and microorganism
WO1998056940A1 (en) Hair growth activating composition
TW202102244A (en) Plant fermented product and uses thereof for protecting liver, improving mitochondrial activity of cells, anti-oxidation, anti-aging, and increasing expression of cct gene, pink1 gene, mrps5 gene, foxo gene and ubl5 gene
US20110123470A1 (en) Natural bioactive compounds
CN1747962A (en) Compound, process for producing the same and use thereof
JP3813733B2 (en) Cosmetics for preventing and improving wrinkles
US6103767A (en) Physiologically active substances TKR1785&#39;s, process for the preparation thereof, and microbe
WO1982000587A1 (en) New metabolites,processes for their production and their use
JPH06345642A (en) H3-receptor stimulant
KR100923539B1 (en) Polypropionate compounds having antifungal and antibacterial activity
TWI557134B (en) Novel compound and fermentation product from colletotrichum aotearoa containing the novel compound, pharmaceutical compositions containing the same, applications of the same and novel colletotrichum aotearoa
JPH11130776A (en) Hair tonic
JPS58198484A (en) Antibiotic x-14873 a,g and h
JP3010215B1 (en) Lipase inhibitor
CN101397303A (en) Sanggenole A compounds, preparation method and use thereof
JPH05331172A (en) New metabolic product obtained from bioactive pseurochin a and d and aspergillus fumigatus, preparation thereof and its use
JPH0725880A (en) Pi3 kinase inhibitor and its production
CN101157696A (en) Mulberry roots phenol A compound, preparation method and application thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA